NeoBiotechnologies is a US-based biotechnology company established in 2013 to produce monoclonal antibodies for research, diagnostics, and therapeutics. As an original manufacturer, NeoBiotechnologies manages the entire antibody production process and offers over 20,000 monospecific antibodies validated for applications in oncology, immunology, neuroscience, and metabolism.
Navigate BioPharma Services
We design innovative biomarker solutions and customized validations based on intended use for clinical development from exploratory to regulated. Our approach is technology agnostic, meaning that we have a selection of platforms and techniques to ensure that you get the right answers. Our teams can apply our genomic, flow, digital pathology, or ligand binding analysis methods for across the spectrum of drug development and manufacturing applications. We collaborate with our clients to achieve shared goals. We offer targeted solutions, end-to-end support, and quality oversight to mitigate the risks and challenges of the regulatory process. Quality is embedded in all of our activities and is owned by each individual, to ensure we do what is right, not just when others are watching. This is the cornerstone of our positive interactions with regulators including EMA, HGRAC, FDA, and CDC. Our deep disease knowledge and team of highly-trained specialists can help you determine which platform will provide the best assessment for your intended use. We know that there are complexities and nuances to the diseases you are developing therapies for, and aligning the questions you need answered with the right analytical method(s) for a particular patient population is critical.
Nacalai USA, Inc.
Nacalai USA is located in San Diego and is a subsidiary of Nacalai Tesque, a reagent company based in Kyoto, Japan. We provide a wide range of research products in the Life Science and Analytical Chemistry fields, including various reagents, 3D cell culture vessels, IHC and protein research related products, HPLC columns, and research chemicals. Our mission is to propose and provide products that enable researchers to conduct their research with ease. If you are having trouble with your research or would like to find products new to you, please stop by our booth!
ModuSystems
ModuSystems delivers advanced motion control and automation solutions for customers who need speed, precision, and scalability. At the core is ModuLYNX, our unified motion platform that connects standardized hardware, intelligent controls, and AI-assisted configuration to eliminate one-off engineering and accelerate deployment. Proof of this concept is Quantyx, a precision liquid-handling automation solution designed for accuracy and repeatability. | ModuSystems is a manufacturer of Motion Controllers, Linear Actuators, and Custom Motion Systems. Systems and Controls are designed to be Modular and Easy to Program, while still meeting the most demanding challenges of multi-axis motion systems.
ModernaTX, Inc.
Moderna is one of the leaders in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency. Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
ModernVivo
ModernVivo develops automated literature review software specifically designed for in vivo researchers. Our platform streamlines the process of searching for and reviewing in-vivo studies, reducing manual workloads that hinder study progress and drives up costs. With ModernVivo’s software, researchers and IACUC committees across pharmaceutical companies, contract research organizations, and academic labs can accelerate timelines, lower operational expenses, and improve translational success.
Moderna
At Moderna, we are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. We are relentlessly working to grow our cancer therapeutic modality by discovering mRNA medicines that harness the body’s immune system to identify and kill cancer cells in the same way the immune system identifies and targets infections. One example of a promising oncology candidate is the creation of individualized, mRNA-based cancer therapies. We also continue to strengthen our portfolio through strategic collaborations that increase our potential to improve treatment options for patients with cancer. | At Moderna, we are grounded in the belief that mRNA is transformational. And, for us, our covid and RSV vaccines are just the beginning. Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health. | Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines.
Minerva Imaging
Minerva Imaging is an integrated CRO and CDMO specialized in targeted radionuclide therapies and molecular imaging. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
Mindpeak Gmbh
Mulitplex Immunofluorescence Image Analysis Workflow. Building artificial intelligence for pathology. We create artificial intelligence to bring precision and speed to clinical pathology and to get more information out of tissue.